API
DGX icon

Advisor Partners II’s Quest Diagnostics DGX Stock Holding History

Advisor Partners II’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$580K Sell
4,759
-212
-4% -$28.2K 0.02% 658
2023
Q2 		$699K Buy
4,971
+118
+2% +$16.3K 0.03% 487
2023
Q1 		$687K Buy
4,853
+632
+15% +$90.4K 0.04% 456
2022
Q4 		$660K Buy
4,221
+461
+12% +$66.2K 0.04% 446
2022
Q3 		$461K Buy
+3,760
New +$495K 0.03% 483

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Advisor Partners II's DGX Position: Q3 2023 in Review

Advisor Partners II reduced its Quest Diagnostics (DGX) stake by 4.3% in Q3 2023, selling an estimated $28.2K and leaving 4,759 shares worth $580K. The position accounts for 0.02% of the portfolio, ranked #658.

Advisor Partners II first reported a position in DGX in Q3 2022 and has held it in 5 quarters since. The position peaked at $699K in Q2 2023. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

  • Advisor Partners II held 4,759 shares of Quest Diagnostics worth $580K as of Q3 2023.
  • Advisor Partners II sold 212 Quest Diagnostics shares in Q3 2023, an estimated $28.2K.
  • Quest Diagnostics made up 0.02% of Advisor Partners II's portfolio in Q3 2023, its #658 holding.
  • Advisor Partners II first reported a position in Quest Diagnostics in Q3 2022 and has held it in 5 quarters since.
  • Advisor Partners II's Quest Diagnostics position peaked at $699K in Q2 2023.
  • 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.